Keywords: European Union, Reference pricing, Parallel imports, EFPIA, Pharma innovation, Threats

EFPIA president warns that European pricing threatens medicines supply flow

Article | 26 June 2012

Europe’s pharmaceutical industry is facing two huge problems: drug reference pricing and parallel trade (the re-exportation of pharmaceutical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in